Rationale for the avoidance of parametrectomy and systematic lymphadenectomy in patients with early stages of neuroendocrine cervical cancer

Neuroendocrine tumors account for only 1–2% of cervical carcinomas, but they are known to have the worst prognosis of all. Given the low incidence, their management is based on retrospective series of small cohorts, and pharmacological treatment is adopted from experience with small cell lung